Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.
about
Neglected parasitic infections in the United States: toxoplasmosisWhy prevent, diagnose and treat congenital toxoplasmosis?Prenatal education for congenital toxoplasmosisPrenatal education for congenital toxoplasmosisPrenatal education for congenital toxoplasmosisPerformance of Polymerase Chain Reaction Analysis of the Amniotic Fluid of Pregnant Women for Diagnosis of Congenital Toxoplasmosis: A Systematic Review and Meta-AnalysisA Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in HumansEmerging Role of Zika Virus in Adverse Fetal and Neonatal OutcomesCongenital toxoplasmosisSeroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital.A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection.Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort studyCongenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-savingStrategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies.Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.Prevention of congenital toxoplasmosis.Use of dense granule antigen GRA6 in an immunoglobulin G avidity test to exclude acute Toxoplasma gondii infection during pregnancy.Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis.Epidemiology of and diagnostic strategies for toxoplasmosisAssessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy.Toxoplasmosis during pregnancy.Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancyToxoplasmosis, cytomegalovirus, listeriosis, and preconception care.Congenital toxoplasmosis and prenatal care state programs.Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant womenUtility of immunoblotting for early diagnosis of toxoplasmosis seroconversion in pregnant women.Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosisSulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?Chorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago-based, Congenital Toxoplasmosis StudyThe national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002Some suggested cautions for pregnant women.Evaluation of the liaison automated testing system for diagnosis of congenital toxoplasmosis.Survey of obstetrician-gynecologists in the United States about toxoplasmosis: 2012 update.Toxoplasmosis - An update.Prevention and treatment of congenital toxoplasmosis.Seroprevalence of toxoplasmosis in antenatal women with bad obstetric historyManagement of Toxoplasma gondii infection during pregnancy.Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot.When are we going to celebrate the centenary of the discovery of efficient treatment for congenital toxoplasmosis?Antibiotics for human toxoplasmosis: a systematic review of randomized trials.
P2860
Q22305416-084AEA92-3073-4B97-9BDF-438B6F210D17Q22305913-6F5E2210-2815-4920-AC27-C61E075DB4F7Q24186404-9AAFA35A-B0A2-4057-8387-FCAB1127A570Q24200555-F50F60B5-AD44-4537-9E68-0A8E41604189Q24241243-547BC410-8240-48B5-B726-8C64ED0B79C2Q26750921-0DA38B71-6AE7-430B-93C9-AB7D0261DC72Q26782186-5F66126E-892F-484D-8B53-2606014AB935Q27010776-AC1B9DA8-2152-4E19-AFF7-D7C6D824A968Q27022566-164249D9-3242-47A4-961D-72B2734FEB79Q30409642-C695E306-9ED6-475D-A65F-AFD0B8BA4C5FQ33618593-0CB50C6F-D11F-4A25-9545-5268B9568220Q33725570-2F737C55-372F-4388-8945-A45DFA8666C0Q33887872-4C259E9C-904A-4E32-BC48-03E19FB6F85EQ33972643-14D93263-BFE9-4938-9E09-00D29FE3AA9AQ34043532-67073651-46B4-4DA4-A23A-D27F46D7D51DQ34110696-EA3E954B-5451-4875-9303-57C9163F8025Q34150450-353C6C94-E432-49F2-9D3E-338D1334EA96Q34231671-9E8E87BB-24AD-4317-BA40-3BBBFEAF06D0Q34267180-94A98EE9-4C5A-4BAB-A447-413CC2F8EF54Q34504353-B6DA0502-063E-4018-BB26-22B478D52149Q34683901-24428185-5929-4C07-8EB4-951B797054EDQ34948181-BAC89AB6-6ACF-4A16-9C6D-2960971CA8CFQ35069449-FAADFDE9-3445-445F-96C7-E65B4D1E87B2Q35085686-AA415FFF-10E4-42EF-A54D-AE406EE3171CQ35523413-0195A5A5-FAAE-4F7C-9053-4E3C2E57D883Q35530254-50DFE08B-AB27-4636-BACD-C27871541523Q35826163-71B07ADC-74C8-413C-9800-731ACB342CEDQ35917170-2A322D37-9ACF-48F5-930D-4E0E64D2AC12Q35945424-AF6F401B-F98E-4B0E-82F0-9E3469D2AF60Q36153569-1456055F-9645-4309-90E0-71ADD14B176CQ36202184-AF782142-247C-4FB5-91E2-3256293370BDQ36378651-6058FA05-7079-4F79-A486-6765D695BF23Q36482662-00CABFFC-B23F-47E4-87AA-9FFB88027C44Q36671583-F04AE1BB-FC6F-4D4E-8AA7-90B383D0A817Q36777857-5BE1EB4D-3A50-4FF1-A2CF-C2F5E8867918Q37100485-678C8EF1-602E-4062-B3DB-F5BD56A09FF5Q37215176-C22BA978-0758-4B76-BBCD-24398BF0F10EQ37349223-AB120221-F09D-4615-8AE8-0CC87664FEC5Q37476768-3BC1EC25-77DF-421F-8714-6DB6EE1F9C4EQ37726477-ED4DDD55-EA35-4309-A7AA-B24F7426874B
P2860
Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Treatment of toxoplasmosis dur ...... dren's sequelae at age 1 year.
@en
Treatment of toxoplasmosis dur ...... dren's sequelae at age 1 year.
@nl
type
label
Treatment of toxoplasmosis dur ...... dren's sequelae at age 1 year.
@en
Treatment of toxoplasmosis dur ...... dren's sequelae at age 1 year.
@nl
prefLabel
Treatment of toxoplasmosis dur ...... dren's sequelae at age 1 year.
@en
Treatment of toxoplasmosis dur ...... dren's sequelae at age 1 year.
@nl
P2093
P1476
Treatment of toxoplasmosis dur ...... dren's sequelae at age 1 year.
@en
P2093
A Decoster
A Naessens
B Stray-Pedersen
M Lappalainen
P304
P356
10.1016/S0002-9378(99)70224-3
P407
P433
P577
1999-02-01T00:00:00Z